Cardiovascular diseases are associated with significant morbidity and mortality, markedly impacting healthcare budgets. Biomarkers play an essential role in the diagnosis and prognosis of cardiovascular diseases. Fibroblast Growth Factor 23 is a hormone regulating phospho-calcium metabolism, which is increasingly emerging as a powerful biomarker of cardiovascular risk.
Key Words
FGF23, biomarker, cardiovascular risk, phospho-calcium